Cargando…
Metformin in pregnancy and risk of abnormal growth outcomes at birth: a register-based cohort study
INTRODUCTION: We previously reported an increased risk of being small for gestational age (SGA) and a decreased risk of being large for gestational age (LGA) after in utero exposure to metformin compared with insulin exposure. This follow-up study investigated if these observations remain when metfo...
Autores principales: | Brand, Kerstin MG, Thoren, Robyn, Sõnajalg, Jaak, Boutmy, Emmanuelle, Foch, Caroline, Schlachter, Judith, Hakkarainen, Katja M, Saarelainen, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723823/ https://www.ncbi.nlm.nih.gov/pubmed/36460329 http://dx.doi.org/10.1136/bmjdrc-2022-003056 |
Ejemplares similares
-
Metformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study
por: Brand, Kerstin M G, et al.
Publicado: (2022) -
Quality and Characteristics of 4241 Case Reports of Lactic Acidosis in Metformin Users Reported to a Large Pharmacovigilance Database
por: Brand, Kerstin M G, et al.
Publicado: (2022) -
Cord serum metabolome and birth weight in patients with gestational diabetes treated with metformin, insulin, or diet alone
por: Huhtala, Mikael S, et al.
Publicado: (2021) -
Long-term metformin adherence in the Diabetes Prevention Program Outcomes Study
por: Walker, Elizabeth Arquin, et al.
Publicado: (2020) -
Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7–9 years of age
por: Rowan, Janet A, et al.
Publicado: (2018)